Understanding Hemophilia A and B Drug Dosage Administration Patterns

Stopped early

Conditions studied: Hemophilia A, Hemophilia B

In brief

Study Design A prospective observational, cross-sectional epidemiological study in U.S. site-based clinical practice settings. 30 sites will enroll approximately 300 patients Participating patients - or their caregiver in the case of patients under the age of 18 - will be consented to participate. Physicians complete a retrospective chart review on each enrolled patient. Patients will complete a one-time study questionnaire.

Key facts

Study ID

NCT03248141

Run by

Pfizer

People needed

11

Starts

2017-09-01

Expected to finish

2018-03-14

Last updated by the study team

2019-05-20

Who can join

Age: any. Sex: any. Healthy volunteers: not accepted.

You may not qualify if…

• Female with hemophilia A or B
• Mild Haemophilia A or B

Where it is running

• University of Florida College of Medicine — Gainesville, Florida, United States
• Alliance for Childhood Diseases, dba Hemophilia Treatment Center of Nevada — Las Vegas, Nevada, United States
• Cook Children's Medical Center — Fort Worth, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.